MHRA Drug Safety Update: Domperidone new contraindication
MHRA Drug Safety Update: Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension. The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension. [...]
The post MHRA Drug Safety Update: Domperidone new contraindication appeared first on Community Pharmacy England.
Recent Comments